Related Experiment Video
Updated: Aug 7, 2026
09:36
Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
The PGH-synthase system and isozyme-selective inhibition
1Department of Pharmacology, University of Rome La Sapienza, Rome, Italy. cpatrono@unich.it
Journal of Cardiovascular Pharmacology
|June 21, 2006
Summary
Cyclooxygenase (COX) enzymes have distinct roles in platelets and blood vessels. Aspirin inhibits platelet COX-1 for atherothrombosis prevention, while coxibs target endothelial COX-2, impacting vascular occlusion.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Medicine
Background:
- Cyclooxygenase (COX)-1 and COX-2 are expressed in most human cell types.
- Both isoforms play roles in physiological and pathophysiological processes.
- Differential expression and function necessitate varied COX inhibition strategies.
Purpose of the Study:
- To explore the distinct roles of COX-1 and COX-2 in human platelets and vascular endothelial cells.
- To understand the implications of differential COX inhibition on cardiovascular homeostasis.
- To differentiate the mechanisms of action for aspirin and coxibs.
Main Methods:
- Analysis of cyclooxygenase (COX) enzyme expression and function.
- Investigation of prostaglandin (PG) biosynthesis pathways.
- Pharmacological studies using aspirin and coxibs.
Main Results:
- Platelets have a high capacity for thromboxane A2 production, requiring significant COX-1 inhibition.
- Vascular endothelial cells have lower PGI2 production capacity, with different COX inhibition requirements.
- Low-dose aspirin effectively inhibits platelet COX-1, impacting atherothrombosis.
- Coxibs highlight the role of endothelial COX-2 in vascular occlusion.
Conclusions:
- Differential requirements for COX inhibition in platelets versus endothelial cells are crucial for therapeutic effects.
- Aspirin's antiplatelet action stems from COX-1 inhibition.
- Coxibs' effects on vascular occlusion involve endothelial COX-2.
- Traditional NSAIDs often mimic coxibs' effects on cardiovascular homeostasis.
Related Concept Videos
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:18ATP Synthase: Structure
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
00:46Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...